Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

2015 Genitourinary Cancers Symposium /
Taxane response in prostate cancer may not be influenced by androgen receptor variations

26th - 28th Feb 2015

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 28.02.15
Views: 2761

Dr Emmanuel Antonarakis - Johns Hopkins School of Medicine, Baltimore, USA

Dr Emmanuel Antonarakis talks to ecancertv at ASCO GU 15 about the results of his small prospective study on the correlation between androgen receptor V7 status and resistance to taxane chemotherapy in men with metastatic castration-resistant prostate cancer.

Read the news story here

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation